Jamela El-Mabrok

Hamad Medical Corporation

Papers

1

Total Citations

40

H-Index

1

About

Dr. Jamela El-Mabrok is a distinguished clinician-researcher whose work has significantly advanced the understanding and management of gastrointestinal stromal tumors (GISTs), particularly within the Middle Eastern population. Her landmark study, "Clinical presentation, management and outcomes of gastrointestinal stromal tumors" (2014), which has garnered 40 citations, provides critical insights into the incidence, clinical presentation, and treatment outcomes of GISTs in Qatar. By conducting a comprehensive retrospective review spanning nearly two decades (1995–2012), Dr. El-Mabrok established foundational epidemiological data for a region where such information was previously scarce. Her research highlights the unique clinical and pathological characteristics of GISTs in this population, offering evidence-based guidance for diagnosis and surgical management. This work has not only informed local clinical practice but has also contributed to the global discourse on GIST variability across ethnic groups. Dr. El-Mabrok’s dedication to bridging gaps in oncological care underscores her impact as a key figure in improving patient outcomes through region-specific research.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Clinical presentation, management and outcomes of gastrointestinal stromal tumors
40 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago